279 related articles for article (PubMed ID: 24155204)
1. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
3. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumor: 15-years' experience in a single center.
Wang M; Xu J; Zhang Y; Tu L; Qiu WQ; Wang CJ; Shen YY; Liu Q; Cao H
BMC Surg; 2014 Nov; 14():93. PubMed ID: 25403624
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
8. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
[TBL] [Abstract][Full Text] [Related]
9. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
10. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
12. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome.
Huang HY; Li CF; Huang WW; Hu TH; Lin CN; Uen YH; Hsiung CY; Lu D
Surgery; 2007 Jun; 141(6):748-56. PubMed ID: 17560251
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis analysis of 247 cases of gastrointestinal stromal tumor].
Ning L; Zhang DF; Zhou YB; Jiao XL; Cao SG
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):247-50. PubMed ID: 23536345
[TBL] [Abstract][Full Text] [Related]
14. Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.
Yen CC; Yeh CN; Cheng CT; Jung SM; Huang SC; Chang TW; Jan YY; Tzeng CH; Chao TC; Chen YY; Yang CY; Ho CL; Fletcher JA
Ann Surg Oncol; 2012 Oct; 19(11):3491-9. PubMed ID: 22588468
[TBL] [Abstract][Full Text] [Related]
15. [Stromal gastrointestinal tumors: retrospective study of 24 cases].
Boudabous H; Chaker Y; Nouira R; Dziri C
Tunis Med; 2013 Nov; 91(11):661-7. PubMed ID: 24343490
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
17. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
[TBL] [Abstract][Full Text] [Related]
18. Two staging systems for gastrointestinal stromal tumors in the stomach: which is better?
Park CH; Kim GH; Lee BE; Song GA; Park DY; Choi KU; Kim DH; Jeon TY
BMC Gastroenterol; 2017 Dec; 17(1):141. PubMed ID: 29207963
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival post surgery for patients with gastrointestinal stromal tumors.
Mrowiec S; Jabłońska B; Liszka L; Pająk J; Leidgens M; Szydło R; Sandecka A; Lampe P
Eur Surg Res; 2012; 48(1):3-9. PubMed ID: 22179138
[TBL] [Abstract][Full Text] [Related]
20. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]